ImmuCell Corporation (ICCC)

ImmuCell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	29	39	47	62	43	37
Market Cap Growth	-31.26%	-16.51%	-23.70%	44.32%	15.59%	-3.93%
Enterprise Value	40	54	51	62	48	36
Last Close Price	3.66	5.09	6.10	8.00	5.95	5.15
PS Ratio	1.21	2.26	2.55	3.22	2.80	2.71
PB Ratio	1.22	1.58	1.56	1.90	1.52	1.28
P/TBV Ratio	1.08	1.59	1.56	1.91	1.53	1.29
P/OCF Ratio	-	-	-	64.91	32.62	159.00
EV/Sales Ratio	1.69	3.10	2.75	3.22	3.13	2.64
EV/EBITDA Ratio	-	-	65.78	22.78	49.62	27.63
EV/EBIT Ratio	-	-	-	240.62	-	-
Debt / Equity Ratio	0.59	0.67	0.41	0.32	0.38	0.29
Debt / EBITDA Ratio	21.73	-	12.96	3.57	9.69	6.46
Asset Turnover	0.54	0.39	0.42	0.45	0.39	0.38
Inventory Turnover	2.28	1.89	2.26	4.09	3.68	2.88
Quick Ratio	1.37	0.76	2.47	5.09	4.44	4.19
Current Ratio	3.11	2.73	4.56	6.42	5.50	5.29
Return on Equity (ROE)	-14.54%	-20.86%	-7.92%	-0.26%	-3.57%	-5.11%
Return on Assets (ROA)	-3.85%	-7.36%	-2.39%	0.38%	-2.18%	-1.67%
Return on Capital (ROIC)	-4.04%	-7.72%	-2.49%	0.39%	-2.26%	-1.73%
Earnings Yield	-13.29%	-14.64%	-5.28%	-0.13%	-2.38%	-3.49%
FCF Yield	-2.49%	-16.64%	-11.68%	-2.67%	-6.42%	-3.12%
Buyback Yield / Dilution	-1.57%	-0.03%	-2.01%	-5.25%	-5.78%	-24.29%
Total Shareholder Return	-1.57%	-0.03%	-2.01%	-5.25%	-5.78%	-24.29%

Source: S&P Capital IQ. Standard template. Financial Sources.